Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.
Identifieur interne : 005419 ( Ncbi/Merge ); précédent : 005418; suivant : 005420Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.
Auteurs : Clare J. Reade [Canada] ; Waldo Jimenez ; Daria O'Reilly ; Al CovensSource :
- Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [ 1701-2163 ] ; 2012.
Descripteurs français
- KwdFr :
- Aine, Analyse coût-bénéfice, Biopsie de noeud lymphatique sentinelle (économie), Canada, Faux négatifs, Femelle, Humains, Lymphadénectomie (effets indésirables), Récidive tumorale locale (anatomopathologie), Technologie biomédicale, Tumeurs de la vulve (), Tumeurs de la vulve (anatomopathologie), Évaluation de la technologie biomédicale.
- MESH :
- anatomopathologie : Récidive tumorale locale, Tumeurs de la vulve.
- effets indésirables : Lymphadénectomie.
- économie : Biopsie de noeud lymphatique sentinelle.
- Aine, Analyse coût-bénéfice, Canada, Faux négatifs, Femelle, Humains, Technologie biomédicale, Tumeurs de la vulve, Évaluation de la technologie biomédicale.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Biomedical Technology, Canada, Cost-Benefit Analysis, False Negative Reactions, Female, Groin, Humans, Lymph Node Excision (adverse effects), Neoplasm Recurrence, Local (pathology), Sentinel Lymph Node Biopsy (economics), Technology Assessment, Biomedical, Vulvar Neoplasms (pathology), Vulvar Neoplasms (surgery).
- MESH :
- geographic : Canada.
- adverse effects : Lymph Node Excision.
- economics : Sentinel Lymph Node Biopsy.
- pathology : Neoplasm Recurrence, Local, Vulvar Neoplasms.
- surgery : Vulvar Neoplasms.
- Biomedical Technology, Cost-Benefit Analysis, False Negative Reactions, Female, Groin, Humans, Technology Assessment, Biomedical.
Abstract
Inguinofemoral lymphadenectomy for vulvar cancer is associated with a high incidence of groin wound complications and lymphedema. Sentinel lymph node biopsy (SLNB) is a morbidity-reducing alternative to lymphadenectomy. The objective of this health technology assessment was to determine the clinical effectiveness, cost-effectiveness, and organizational feasibility of SLNB in the Canadian health care system.
PubMed: 23231843
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001E11
- to stream PubMed, to step Curation: 001E11
- to stream PubMed, to step Checkpoint: 001E11
Links to Exploration step
pubmed:23231843Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.</title><author><name sortKey="Reade, Clare J" sort="Reade, Clare J" uniqKey="Reade C" first="Clare J" last="Reade">Clare J. Reade</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecologic Oncology, University of Toronto, Toronto ON, Health Research Methodology Program, McMaster University, Hamilton ON.</nlm:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Jimenez, Waldo" sort="Jimenez, Waldo" uniqKey="Jimenez W" first="Waldo" last="Jimenez">Waldo Jimenez</name></author><author><name sortKey="O Reilly, Daria" sort="O Reilly, Daria" uniqKey="O Reilly D" first="Daria" last="O'Reilly">Daria O'Reilly</name></author><author><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23231843</idno><idno type="pmid">23231843</idno><idno type="wicri:Area/PubMed/Corpus">001E11</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E11</idno><idno type="wicri:Area/PubMed/Curation">001E11</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E11</idno><idno type="wicri:Area/PubMed/Checkpoint">001E11</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E11</idno><idno type="wicri:Area/Ncbi/Merge">005419</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.</title><author><name sortKey="Reade, Clare J" sort="Reade, Clare J" uniqKey="Reade C" first="Clare J" last="Reade">Clare J. Reade</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecologic Oncology, University of Toronto, Toronto ON, Health Research Methodology Program, McMaster University, Hamilton ON.</nlm:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Jimenez, Waldo" sort="Jimenez, Waldo" uniqKey="Jimenez W" first="Waldo" last="Jimenez">Waldo Jimenez</name></author><author><name sortKey="O Reilly, Daria" sort="O Reilly, Daria" uniqKey="O Reilly D" first="Daria" last="O'Reilly">Daria O'Reilly</name></author><author><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name></author></analytic><series><title level="j">Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC</title><idno type="ISSN">1701-2163</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomedical Technology</term><term>Canada</term><term>Cost-Benefit Analysis</term><term>False Negative Reactions</term><term>Female</term><term>Groin</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Neoplasm Recurrence, Local (pathology)</term><term>Sentinel Lymph Node Biopsy (economics)</term><term>Technology Assessment, Biomedical</term><term>Vulvar Neoplasms (pathology)</term><term>Vulvar Neoplasms (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Aine</term><term>Analyse coût-bénéfice</term><term>Biopsie de noeud lymphatique sentinelle (économie)</term><term>Canada</term><term>Faux négatifs</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie (effets indésirables)</term><term>Récidive tumorale locale (anatomopathologie)</term><term>Technologie biomédicale</term><term>Tumeurs de la vulve ()</term><term>Tumeurs de la vulve (anatomopathologie)</term><term>Évaluation de la technologie biomédicale</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Récidive tumorale locale</term><term>Tumeurs de la vulve</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Neoplasm Recurrence, Local</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Biomedical Technology</term><term>Cost-Benefit Analysis</term><term>False Negative Reactions</term><term>Female</term><term>Groin</term><term>Humans</term><term>Technology Assessment, Biomedical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Aine</term><term>Analyse coût-bénéfice</term><term>Canada</term><term>Faux négatifs</term><term>Femelle</term><term>Humains</term><term>Technologie biomédicale</term><term>Tumeurs de la vulve</term><term>Évaluation de la technologie biomédicale</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Inguinofemoral lymphadenectomy for vulvar cancer is associated with a high incidence of groin wound complications and lymphedema. Sentinel lymph node biopsy (SLNB) is a morbidity-reducing alternative to lymphadenectomy. The objective of this health technology assessment was to determine the clinical effectiveness, cost-effectiveness, and organizational feasibility of SLNB in the Canadian health care system.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23231843</PMID><DateCreated><Year>2012</Year><Month>12</Month><Day>12</Day></DateCreated><DateCompleted><Year>2014</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2012</Year><Month>12</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1701-2163</ISSN><JournalIssue CitedMedium="Print"><Volume>34</Volume><Issue>11</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC</Title><ISOAbbreviation>J Obstet Gynaecol Can</ISOAbbreviation></Journal><ArticleTitle>Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.</ArticleTitle><Pagination><MedlinePgn>1053-65</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Inguinofemoral lymphadenectomy for vulvar cancer is associated with a high incidence of groin wound complications and lymphedema. Sentinel lymph node biopsy (SLNB) is a morbidity-reducing alternative to lymphadenectomy. The objective of this health technology assessment was to determine the clinical effectiveness, cost-effectiveness, and organizational feasibility of SLNB in the Canadian health care system.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A review of the English-language literature published from January 1992 to October 2011 was performed across five databases and six grey-literature sources. Predetermined eligibility criteria were used to select studies, and results in the clinical, economic, and organizational domains were summarized. Included studies were evaluated for methodologic quality using the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 825 reports identified, 88 observational studies met the eligibility criteria. Overall study quality was poor, with a median Newcastle-Ottawa Scale score of 2 out of 9 stars. Across all studies, the detection rate of the sentinel lymph node was 82.2% per groin and the false-negative rate was 6.3%. The groin recurrence rate after negative SLNB was 3.6% compared with 4.3% after negative lymphadenectomy, and complications were reduced after SLNB. No economic evaluations were identified comparing SLNB to lymphadenectomy. Safe implementation of SLNB requires appropriate patient selection, detection technique, and attention to the learning curve.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although study quality is poor, the available data suggest implementation of SLNB may be safe and feasible in Canadian centres with adequate procedural volumes, assuming that implementation includes careful patient selection, careful technique, and ongoing quality assessment. Cost-effectiveness has yet to be determined.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reade</LastName><ForeName>Clare J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, University of Toronto, Toronto ON, Health Research Methodology Program, McMaster University, Hamilton ON.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Waldo</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>O'Reilly</LastName><ForeName>Daria</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Covens</LastName><ForeName>Al</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Obstet Gynaecol Can</MedlineTA><NlmUniqueID>101126664</NlmUniqueID><ISSNLinking>1701-2163</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020811" MajorTopicYN="N">Biomedical Technology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005188" MajorTopicYN="N">False Negative Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006119" MajorTopicYN="N">Groin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="Y">Sentinel Lymph Node Biopsy</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013673" MajorTopicYN="N">Technology Assessment, Biomedical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014846" MajorTopicYN="N">Vulvar Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23231843</ArticleId><ArticleId IdType="pii">S1701-2163(16)35435-4</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><noCountry><name sortKey="Covens, Al" sort="Covens, Al" uniqKey="Covens A" first="Al" last="Covens">Al Covens</name><name sortKey="Jimenez, Waldo" sort="Jimenez, Waldo" uniqKey="Jimenez W" first="Waldo" last="Jimenez">Waldo Jimenez</name><name sortKey="O Reilly, Daria" sort="O Reilly, Daria" uniqKey="O Reilly D" first="Daria" last="O'Reilly">Daria O'Reilly</name></noCountry><country name="Canada"><region name="Ontario"><name sortKey="Reade, Clare J" sort="Reade, Clare J" uniqKey="Reade C" first="Clare J" last="Reade">Clare J. Reade</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005419 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 005419 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:23231843
|texte= Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:23231843" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |